Tehran University of Medical Sciences

Science Communicator Platform

Share By
Design, Synthesis, and Antidiabetic Evaluation of Triazolopyrimidine Thioacetamides As Potent and Selective Α-Glucosidase Inhibitors Publisher Pubmed



Peytam F ; Norouzbahari M ; Bayati B ; Gulcan HO ; Sheibani V ; Barazandeh Tehrani M ; Mojtabavi S ; Faramarzi MA ; Ghasemi F ; Torabi M ; Payab M ; Safari F ; Firoozpour L ; Foroumadi A
Authors

Source: Bioorganic Chemistry Published:2026


Abstract

Diabetes mellitus is a global health challenge characterized by chronic hyperglycemia. α -Glucosidase inhibitors, like acarbose, are pivotal in managing postprandial blood glucose levels but are often associated with gastrointestinal side effects. This study aimed to rationally design and synthesize a library of 2-((6-amino-5,7-diaryl-[1,2,4]triazolo[1,5- a ]pyrimidin-2-yl)thio)- N -arylacetamide derivatives ( 15a-15ae ) as potent and selective α -glucosidase inhibitors. All 31 target compounds exhibited inhibitory activity (IC50 ranging from 7.09 μM to 245.57 μM) under assay conditions where the reference drug, acarbose, exhibited an IC50 value of 750.67 μM. The most potent compound, 15o (IC50 = 7.09 ± 0.2 μM), demonstrated approximately 106-fold higher potency than acarbose under the identical assay conditions. Kinetic analysis indicated that 15o acted as a competitive inhibitor (Ki = 6.9 μM). Moreover, this compound did not show α -amylase inhibitory activity and cytotoxicity at concentration of 100 μM, showing preliminary indications of favorable safety and selectivity. Spectroscopic studies (CD, fluorescence) and computational analyses (model performance and augmentation, docking, and MD simulations) confirmed the strong binding affinity and stabilization of compound 15o within the enzyme's active site. In vivo evaluation in a diabetic rat model demonstrated that 15o (30 mg/kg BW) significantly reduced fasting blood glucose, improved glucose tolerance in OGTT, reduced HbA1c levels to near-normal ranges, and restored hepatic and pancreatic histology, with effects better than those observed with acarbose in this model. Compound 15o also exhibited acceptable acute toxicity profiles. These findings introduced compound 15o as a promising lead candidate for further structural development of anti-diabetic agents. © 2026 Elsevier Inc.
Related Docs
View other Related Docs
1. Preparation of Novel 3,4,5-Triaryl-1,2,4-Oxadiazole Derivatives: Molecular Docking and Α-Glucosidase Assessment, ChemistrySelect (2024)
2. New Coumarin–Chalcone–Triazole Hybrids As Promising Anti-Diabetic Agents: From Molecular Design to in Vivo Validation, RSC Advances (2025)
3. Design, Synthesis, and Investigation of Novel 5-Arylpyrazole-Glucose Hybrids As Α-Glucosidase Inhibitors, Scientific Reports (2025)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Faramarzi (14)
Mohammad Mahdavi (13)
Other Related Docs
4. Development of Coumarin Tagged 1,2,3-Triazole Derivatives Targeting Α-Glucosidase Inhibition: Synthetic Modification, Biological Evaluation, Kinetic and in Silico Studies, Journal of Molecular Structure (2023)
5. New Acridine-9-Carboxamide Linked to 1,2,3-Triazole-N-Phenylacetamide Derivatives As Potent Α-Glucosidase Inhibitors: Design, Synthesis, in Vitro, and in Silico Biological Evaluations, Medicinal Chemistry Research (2020)
6. Enzyme Inhibition, Kinetic, and Molecular Docking Studies of Α-Glucosidase, Current Enzyme Inhibition (2020)
7. Design, Synthesis, in Vitro Anti-Α-Glucosidase Evaluations, and Computational Studies of New Phthalimide-Phenoxy-1,2,3-Triazole-N-Phenyl (Or Benzyl) Acetamides As Potential Anti-Diabetic Agents, Scientific Reports (2023)
8. Discovery of Novel 4,5-Diphenyl-Imidazol-Α-Aminophosphonate Hybrids As Promising Anti-Diabetic Agents: Design, Synthesis, in Vitro, and in Silico Enzymatic Studies, Bioorganic Chemistry (2023)
9. Design, Synthesis, in Vitro, and in Silico Studies on Promising Α-Glucosidase Inhibitors Based on a Quinazolinone–Thiophene Scaffold, RSC Advances (2026)
10. Design, Synthesis, and Evaluation of the Rhodanine-3-Propanoic Acid-Phenoxy-1,2,3-Triazole-Acetamide Derivatives As Active Agents Against Α-Glucosidase, Α-Amylase, and Protein Tyrosine Phosphatase 1B, Journal of Molecular Structure (2026)
11. Design, Synthesis, Α-Glucosidase Inhibition and Hypoglycemic Activity of 3-Aceto(Benzo)Hydrazide-1,2,4-Triazines As Potential Anti-Diabetic Agents, European Journal of Medicinal Chemistry Reports (2024)
12. Synthesis, in Vitro Potency of Inhibition, Enzyme Kinetics and in Silico Studies of Quinoline-Based Α-Glucosidase Inhibitors, Scientific Reports (2024)
13. Introduction of New Quinolone-2-Thio-Acetamide-Propane Hydrazide-Benzimidazole Derivatives As New Α-Glucosidase and Α-Amylase Inhibitors, Scientific Reports (2025)
14. Potent Α-Glucosidase Inhibitors With Benzimidazole-Propionitrile Hybridization; Synthesis, Bioassay and Docking Study, Future Medicinal Chemistry (2024)
15. Naphthoquinone-Triazole Hybrids As Anti-Diabetic Agents: An Exploration of in Silico and in Vitro Α-Glucosidase and Α-Amylase Inhibition, Letters in Drug Design and Discovery (2025)
16. Substituted Piperazine Conjugated to Quinoline-Thiosemicarbazide As Potent Α-Glucosidase Inhibitors to Target Hyperglycemia, Scientific Reports (2025)
17. Synthesis and Biological Assessment of Benzimidazole-Acrylonitrile-1,2,3-Triazole Derivatives As Α-Glucosidase Inhibitors, Bioorganic Chemistry (2025)
18. Design, Synthesis, and in Silico Studies of Benzimidazole Bearing Phenoxyacetamide Derivatives As Α-Glucosidase and Α-Amylase Inhibitors, Journal of Molecular Structure (2022)
19. Pyrano[2,3-B]Chromone Derivatives As Novel Dual Inhibitors of Α-Glucosidase and Α-Amylase: Design, Synthesis, Biological Evaluation, and in Silico Studies, Bioorganic Chemistry (2024)
20. New 1E,1′E-Hydrazine-Bis(Phenoxy-1,2,3-Triazol-Acetamide) Derivatives As Potent Inhibitors Against Acetylcholinesterase, Butyrylcholinesterase, and Α-Glucosidase, RSC Advances (2025)